Monitoring of tobramycin in human plasma via mixed matrix membrane extraction prior to capillary electrophoresis with contactless conductivity detection


    loading  Checking for direct PDF access through Ovid

Abstract

HIGHLIGHTSDynamic mixed matrix membrane tip extraction was demonstrated.Hydrophilic lipophilic balance particles were incorporated into membrane.LOD and LOQ of the method were found to be 10 and 30ng/mL respectively.The developed approach covers the therapeutic range of tobramycin in human plasma.A sample pre-treatment method based on a dynamic mixed matrix membrane tip extraction followed by capillary electrophoresis with contactless conductivity detection (CE-C4D) was evaluated for the determination of tobramycin in human plasma. The extraction tip device consisted of a cellulose triacetate membrane tip wall immobilised with 15% (w/w) of hydrophilic lipophilic balance (HLB) nanoparticles as adsorbent. The extraction was performed dynamically by withdrawing/dispensing the plasma sample through the tip device followed by desorption into 20μL of acidified aqueous solution at pH 3 prior to the CE-C4D analysis. Under the optimum conditions, the detection limit of the method for tobramycin was 10ng/mL, with intraday and interday repeatability RSDs of 3.5% and 4.5%, respectively. Relative recoveries in spiked human plasma were 99.6%–99.9%. The developed approach was successfully demonstrated for the quantification of tobramycin in human plasma samples.

    loading  Loading Related Articles